Qube Research & Technologies LTD Sorrento Therapeutics, Inc. Transaction History

Qube Research & Technologies LTD

  • $65.7 Billion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023
BUY
$0.74 - $1.83 $525,725 - $1.3 Million
710,440 Added 219.08%
1,034,729 $920,000
Q3 2022

Nov 14, 2022
BUY
$1.51 - $2.88 $417,357 - $796,020
276,396 Added 577.11%
324,289 $509,000
Q2 2022

Aug 15, 2022
SELL
$1.24 - $2.33 $312,001 - $586,260
-251,614 Reduced 84.01%
47,893 $96,000
Q1 2022

May 09, 2022
BUY
$2.0 - $4.9 $549,338 - $1.35 Million
274,669 Added 1105.84%
299,507 $698,000
Q4 2021

Feb 01, 2022
BUY
$4.65 - $7.23 $115,496 - $179,578
24,838 New
24,838 $115,000

Others Institutions Holding SRNE

# of Institutions
12
Shares Held
5.47M
Call Options Held
0
Put Options Held
0
View Full List

About Sorrento Therapeutics, Inc.

SRNE Quotes by TradingView
  • Ticker SRNE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 449,952,000
  • Market Cap $148M
  • Description
  • Sorrento Therapeutics, Inc., a clinical stage and commercial biopharmaceutical company, develops therapies for cancer, autoimmune, inflammatory, viral, and neurodegenerative diseases. It operates through two segments, Sorrento Therapeutics and Scilex. The company provides cancer therapeutic by leveraging its proprietary G-MAB antibody library an...
More about SRNE
Track This Portfolio

Track Qube Research & Technologies LTD Portfolio

Follow Qube Research & Technologies LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Qube Research & Technologies LTD, based on Form 13F filings with the SEC.

News

Stay updated on Qube Research & Technologies LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email